Skip to main content
  • Correspondence
  • Open access
  • Published:

Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”

A Letter to the Editor to this article was published on 20 February 2024


To the Editor,

We read the article on precision net ultrafiltration by Murugan et al. [1] with concern. In this article, in addition to the misplaced use of the term continuous kidney replacement therapy instead of continuous renal replacement therapy (CRRT) [2], the main author subverts the very definition of net ultrafiltration (NUF), which he had previously espoused, advocated, and published [3, 4]. Moreover, he destabilises the accepted consensus nomenclature published by the Acute Disease Quality Initiative, which is that NUF is the difference between the effluent removed by the CRRT machine through the process of ultrafiltration and the dialysate and replacement fluid administered via the machine.

In contradiction to their previously determined description and against consensus nomenclature [5], the authors confuse the NUF with the fluid balance (the balance between what is removed by the machine (NUF) and all other fluid losses minus fluid inputs). The article then proceeds (Box 1) to describe an evidence-free process where unnecessary adjustments are made based on incomplete fluid balance. Adjustments that do not take into consideration the complex nature of fluid balance in critically ill patients, such as urinary output (which would occur in polyuric acute kidney injury (AKI), drains (as may be common and substantial after cardiac surgery or abdominal surgery), gastrointestinal losses (as may occur and be substantial in a proportion of critically ill patients), or nutritional input (as a major component of fluid input) are simply wrong.

We acknowledge that people can be free to call a platypus a duck. However, to do so causes unnecessary confusion and impedes the process of reproducible, clear, and consistent clinical research and terminology. As such it needs to be called out as both incorrect and undesirable. We invite the authors to join the rest of the world and adopt the accepted terminology in the future.

Availability of data and materials

Not applicable.

References

  1. Murugan R, Kashani K, Palevsky PM (2023) Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach. Intensive Care Med Exp 11(1):83

    Article  PubMed  PubMed Central  Google Scholar 

  2. Bellomo R, Ronco C, Kellum J, Reis T, Forni L (2023) How renal is the kidney? Lancet 402:1527

    Article  PubMed  Google Scholar 

  3. Murugan R, Kerti SJ, Chang C-CH et al (2019) Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous veno-venous hemodiafiltration. JAMA Netw Open 2(6):e195418

    Article  PubMed  PubMed Central  Google Scholar 

  4. Murugan R, Kerti SJ, Chang C-CH et al (2022) Association between net ultrafiltration rate and renal recovery among critically ill adults with acute kidney injury receiving continuous renal replacement therapy: an observational cohort study. Blood Purif 51:397–409

    Article  CAS  PubMed  Google Scholar 

  5. Reis T, Ronco C, Soranno D et al (2023) Standardization of nomenclature of the mechanisms and materials utilized for extracorporeal blood purification. Blood Purif. https://doi.org/10.1159/000533330

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The RENAL Investigators: Kyle White: Department of Intensive Care, Princess Alexandra Hospital, Brisbane, Australia; Akinori Maeda: Department of Intensive Care, Austin Hospital, Melbourne, Australia; Emily See: Department of Intensive care, Royal Melbourne Hospital, Melbourne, Australia. Department of Nephrology, Royal Melbourne Hospital, Melbourne, Australia; Lui Forni: Department of Critical Care, Royal Surrey Hospital Foundation Trust, Guilford, United Kingdom. School of Medicine, Faculty of Health Sciences, University of Surrey, Guilford, United Kingdom; Claudio Ronco: Department of Medicine, Padua University, Padua, Italy. Department of Nephrology, San Bortolo Hospital, Vicenza, Italy. Department of Nephrology, International Renal Research Institute, Vicenza, Italy; Ary Serpa Neto: Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia; Thiago Reis: Department of Nephrology, Dialysis and Kidney Transplantation, Fenix Nephrology, Sao Paulo, Brazil. Department of Intensive Care Nephrology, Syrian-Lebanese Hospital, Sao Paulo, Brazil. Laboratory if Molecular Pharmacology, Faculty of Health Sciences, University of Brasilia, Brasilia, Brazil; Fernando Zampieri: Department of Critical Care, Faculty of Medicine and Dentistry, University of Alberta and Alberta Health Services, Edmonton, Canada; Rinaldo Bellomo.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

RB wrote the first draft of the correspondence. The other investigators read, contributed to changes, and approved the correspondence.

Corresponding author

Correspondence to Rinaldo Bellomo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors have read the correspondence and agree to submit iand publish it.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bellomo, R., the Rational Evaluation of Nomenclature and Agreement based on Logic (RENAL) Investigators. Correspondence regarding the article by Murugan et al. on “Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach”. ICMx 12, 18 (2024). https://doi.org/10.1186/s40635-023-00585-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40635-023-00585-5